Study to Determine Effect of Exendin-9,39 Infusion on Insulin Secretion
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 17-010700
Sponsor Protocol Number: 17-010700
About this study
The purpose of this study is to determine the effect of duration of exendin-9,39 infusion on insulin secretion.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Previous study participants.
- Eligible subjects willing too come to the CRTU for a screening visit.
Exclusion Criteria:
- Age <20 or >65.
- BMI <18 or >35 Kg/M2.
- For female subjects a positive pregnancy test.
- Any systemic illness.
- History of chronic medical illnesses.
- Any medication that could affect glucose metabolism
- Prior abdominal surgery other than cholecystectomy, appendectomy or tubal ligation.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Adrian Vella, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available